companydata.dkSolid Therapeutics ApS: Financial statements 2025
CVR: 43007068
Solid Therapeutics ApS (CVR 43007068) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity amounted to DKK -15,353,766. The company had 3 employees in the financial year.
- Gross Profit
- -1,687,751 kr.
- Profit/Loss
- -4,355,625 kr.
- Equity
- -15,353,766 kr.
- Total Assets
- 6,842,364 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -1.7 mio. | -4.4 mio. | -15.4 mio. | 3 |
| 2024 | - | -4.2 mio. | -6.8 mio. | -11 mio. | 4 |
| 2023 | - | -2.7 mio. | -3.5 mio. | -4.2 mio. | 2 |
| 2022 | - | -398 t. | -797 t. | -757 t. | 1 |
Find more companies like Solid Therapeutics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of August 28, 2025, John Sørensen Haurum is registered as adm. dir. of Solid Therapeutics ApS.
As of August 28, 2025, Anne Mette Hyldgaard Trauelsen has stepped down as adm. dir. of Solid Therapeutics ApS.
Solid Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -4,213,656, and the net result was DKK -6,758,207.
About Solid Therapeutics ApS
Solid Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of John Sørensen Haurum. The company's owners include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity amounted to DKK -15,353,766.